A.P. Carvalho

1.1k total citations
27 papers, 492 citations indexed

About

A.P. Carvalho is a scholar working on Infectious Diseases, Virology and Oncology. According to data from OpenAlex, A.P. Carvalho has authored 27 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 14 papers in Virology and 4 papers in Oncology. Recurrent topics in A.P. Carvalho's work include HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (14 papers) and HIV/AIDS Research and Interventions (8 papers). A.P. Carvalho is often cited by papers focused on HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (14 papers) and HIV/AIDS Research and Interventions (8 papers). A.P. Carvalho collaborates with scholars based in Portugal, Belgium and Brazil. A.P. Carvalho's co-authors include Ricardo Camacho, Perpétua Gómes, Anne–Mieke Vandamme, Ana Abecasis, Koen Deforche, Maria S. Santos, Carlos B. Duarte, María Celeste Lopes, Margarida Gonçalo and Maria Teresa Cruz and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Circulation Research.

In The Last Decade

A.P. Carvalho

27 papers receiving 468 citations

Peers

A.P. Carvalho

VIROL

CAM

EPIDE

Debjani Guha India

Marco Aurélio Echart Montano Italy

Joseph Jablonski United States

Sonia Mediouni United States

Binlian Sun China

Cari F. Kessing United States

Mario Canki United States

Fadoua Daouad France

Byung Oh Kim South Korea

Debjani Guha India

A.P. Carvalho

76 ×0.3

186 ×0.7

VIROL

136 ×2.0

60 ×1.1

CAM

55 ×1.2

EPIDE

Citations per year, relative to A.P. Carvalho A.P. Carvalho (= 1×) peers Debjani Guha

Countries citing papers authored by A.P. Carvalho

Since Specialization

Citations

This map shows the geographic impact of A.P. Carvalho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.P. Carvalho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.P. Carvalho more than expected).

Fields of papers citing papers by A.P. Carvalho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.P. Carvalho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.P. Carvalho. The network helps show where A.P. Carvalho may publish in the future.

Co-authorship network of co-authors of A.P. Carvalho

This figure shows the co-authorship network connecting the top 25 collaborators of A.P. Carvalho. A scholar is included among the top collaborators of A.P. Carvalho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.P. Carvalho. A.P. Carvalho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carvalho, A.P., et al.. (2018). Characterization of NS5A and NS5B Resistance-Associated Substitutions from Genotype 1 Hepatitis C Virus Infected Patients in a Portuguese Cohort. Viruses. 10(5). 223–223. 6 indexed citations

Martı́n, Francisco, Claudia Palladino, Rita Mateus, et al.. (2017). Early infant diagnosis of HIV-1 infection in Luanda, Angola, using a new DNA PCR assay and dried blood spots. PLoS ONE. 12(7). e0181352–e0181352. 9 indexed citations

Bártolo, Inês, Francisco Martı́n, Claudia Palladino, et al.. (2014). HIV-1 Diversity, Transmission Dynamics and Primary Drug Resistance in Angola. PLoS ONE. 9(12). e113626–e113626. 14 indexed citations

Palladino, Claudia, Verónica Briz, José M. Bellón, et al.. (2013). Predictors of Attrition and Immunological Failure in HIV-1 Patients on Highly Active Antiretroviral Therapy from Different Healthcare Settings in Mozambique. PLoS ONE. 8(12). e82718–e82718. 23 indexed citations

Gómes, Perpétua, et al.. (2013). Comparison of the NucliSENS EasyQ HIV-1 v2.0 with Abbott m2000rt RealTime HIV-1 assay for plasma RNA quantitation in different HIV-1 subtypes. Journal of Virological Methods. 193(1). 18–22. 10 indexed citations

Abecasis, Ana, et al.. (2011). Molecular Epidemiological Analysis of Paired pol/env Sequences from Portuguese HIV Type 1 Patients. AIDS Research and Human Retroviruses. 27(7). 803–805. 11 indexed citations

Vercauteren, Jurgen, Itzchak Levy, H Rudich, et al.. (2010). Expected HIV-1 etravirine resistance after treatment failure with efavirenz and/or nevirapine. Antiviral Therapy. 15(4). 1 indexed citations

Abecasis, Ana, et al.. (2009). Effect of human immunodeficiency virus type 1 protease inhibitor therapy and subtype on development of resistance in subtypes B and G. Infection Genetics and Evolution. 10(3). 373–379. 9 indexed citations

Vercauteren, Jurgen, Koen Deforche, Kristof Theys, et al.. (2008). The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001–2006) in Portugal. Retrovirology. 5(1). 12–12. 33 indexed citations

10.

Abecasis, Ana, Koen Deforche, Joke Snoeck, et al.. (2006). Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G (vol 20, pg 1789, 2006). 1 indexed citations

11.

Deforche, Koen, Ricardo Camacho, Zehava Grossman, et al.. (2006). Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors. Infection Genetics and Evolution. 7(3). 382–390. 26 indexed citations

12.

Gómes, Perpétua, et al.. (2006). Comparison of the COBAS TAQMAN™ HIV-1 HPS with VERSANT HIV-1 RNA 3.0 Assay (bDNA) for plasma RNA quantitation in different HIV-1 subtypes. Journal of Virological Methods. 135(2). 223–228. 11 indexed citations

13.

Abecasis, Ana, Koen Deforche, Joke Snoeck, et al.. (2005). Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G. AIDS. 19(16). 1799–1806. 67 indexed citations

14.

Abecasis, Ana, Dimitrios Paraskevis, Inês Bártolo, et al.. (2004). HIV-1 genetic variants circulation in the North of Angola. Infection Genetics and Evolution. 5(3). 231–237. 19 indexed citations

15.

Abecasis, Ana, Perpétua Gómes, Inge Derdelinckx, et al.. (2003). L891/V: a novel mutation selected by protease inhibitor therapy in subtype G, but not in subtype B-infected patients. Antiviral Therapy. 8(3). 3 indexed citations

16.

Cruz, Maria Teresa, Carlos B. Duarte, Margarida Gonçalo, A.P. Carvalho, & María Celeste Lopes. (2001). LPS Induction of IκB-α Degradation and iNOS Expression in a Skin Dendritic Cell Line Is Prevented by the Janus Kinase 2 Inhibitor, Tyrphostin B42. Nitric Oxide. 5(1). 53–61. 44 indexed citations

17.

Carvalho, A.P., et al.. (1998). Epstein-Barr virus infection in children with AIDS. Jornal de Pediatria. 74(2). 125–34. 2 indexed citations

18.

Carvalho, A.P., et al.. (1997). Study of 176 HIV-seropositive children in Santa Catarina State. Jornal de Pediatria. 73(2). 80–87. 1 indexed citations

19.

Santos, Maria S., Paula P. Gonçalves, & A.P. Carvalho. (1990). Effect of ouabain on the gamma-[3H]aminobutyric acid uptake and release in the absence of Ca(+)+ and K(+)-depolarization.. Journal of Pharmacology and Experimental Therapeutics. 253(2). 620–627. 29 indexed citations

20.

Carvalho, A.P., et al.. (1988). An outbreak of cryptosporidiosis in a hospital day-care centre. Epidemiology and Infection. 101(2). 355–359. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact